News from the American Diabetes Association’s Scientific Sessions

Key stories from this year’s American Diabetes Association Scientific Sessions, presented by the Journal of Diabetes Nursing.

Save, Share, Print Article

Share this article

+ Add to reading list – Remove from reading list

To celebrate #DiabetesWeek (13–19 June), the Journal of Diabetes Nursing is sharing the latest news from the American Diabetes Association meeting that took place in New Orleans last week.

Click here to read the report.

New price deal improves access to real-time CGM

New DVLA rules allow specialist nurses to assess fitness to drive

News from the American Diabetes Association’s Scientific Sessions

Tirzepatide reduces body weight by up to 22.5% in participants with overweight or obesity

UK Kidney Association releases guideline on SGLT2 inhibitor use

EMPEROR-Preserved: Empagliflozin first therapeutic agent to demonstrate benefits in people with HFpEF

Dapagliflozin approved in the EU for treatment of CKD in people with and without type 2 diabetes

New price deal improves access to real-time CGM

New price deal puts the Dexcom ONE real-time CGM device at a similar price to flash monitoring.

2 Aug 2022

New DVLA rules allow specialist nurses to assess fitness to drive

Registered healthcare professionals, including those registered with the NMC and HCPC, can now be authorised to assess fitness to drive.

28 Jul 2022

Tirzepatide reduces body weight by up to 22.5% in participants with overweight or obesity

Top-line results from the SURMOUNT-1 clinical trial.

5 May 2022

UK Kidney Association releases guideline on SGLT2 inhibitor use

The UK Kidney Association has released its Clinical Practice Guideline on SGLT2 inhibitor use in adults with kidney disease.

19 Oct 2021

For the latest news and articles

Resources

Journals

Useful information

;